SCHEMBL22250033

SCHEMBL22250033

c1ccc(-c2ccc3ccc4ccc(-c5cnc6oc7cc8c9ccccc9c9ccccc9c8cc7c6c5)nc4c3n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.34
IDO1 P14902 3/20 0.33
TDO2 P48775 3/20 0.33
PARP1 P09874 1/20 0.33
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
CDK1 P06493 2/20 0.32
CCNB1 P14635 2/20 0.32
CCNE1 P24864 2/20 0.32
CDK2 P24941 2/20 0.32
PDE4D Q08499 1/20 0.32
CCNE2 O96020 1/20 0.32
CDK5 Q00535 1/20 0.32
CDK5R1 Q15078 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
CDK4 P11802 1/20 0.31
CCND1 P24385 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRG2 P18507 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22249738 0.83 MEN1 (0.41) GSK3BMAPK1KMT2ANPC1RAB9A
SCHEMBL22249755 0.81 KMT2A (0.39) PARP1MAPK1KMT2ANPC1RAB9A
SCHEMBL22249726 0.78 KDM4E (0.32) PDE4DNPC1
SCHEMBL15581886 0.76 KDM4E (0.42) MAPK1KMT2APIM1PIM3PIM2
SCHEMBL22260264 0.75 KMT2A (0.36) PARP1MAPK1KMT2APDE4DRAB9A
SCHEMBL19767993 0.75 PARP1 (0.41) IDO1TDO2PARP1NPC1RAB9A
SCHEMBL22260502 0.75 ABCG2 (0.40) PARP1MAPK1KMT2ANPC1RAB9A
SCHEMBL22260524 0.74 MAPK1 (0.38) PARP1MAPK1KMT2ANPC1RAB9A
SCHEMBL26120274 0.74 PARP1 (0.44) PARP1KMT2ARAB9AAURKAADORA2A
SCHEMBL17789447 0.73 CCR1 (0.39) MAPK1KMT2APDE4DNPC1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, PIEZO1, ODC1 GSK3B 3913/4885IDO1 2143/4885TDO2 1197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.